Figure 1

Course of AchR-ab over almost three years, showing a positive effect of immunosuppression at onset and after the fifth myasthenic crises despite PSC.
Course of AchR-ab over almost three years, showing a positive effect of immunosuppression at onset and after the fifth myasthenic crises despite PSC.